Thursday, March 10, 2011

COMPANION trial

The COMPANION trial is the largest heart failure device trial to date. The trial shows that cardiac resynchronization therapy (CRT),
used in combination with optimal pharmacologic therapy (OPT), can significantly improve both the quality and duration of life for a large group
of heart failure patients.

The COMPANION trial followed more than 1500 heart failure patients from 128 US center.